Parkinson's disease (PD) is a debilitating and progressive neurodegenerative disorder caused by the loss of ...

Gain Therapeutics, Inc., a clinical-stage biotechnology company, announced that it will present its lead drug candidate, GT-02287, at the International Association of Parkinsonism and Related ...

Berwyn, Pennsylvania--(Newsfile Corp. - March 8, 2022) - Annovis Bio, Inc. (NYSE: ANVS) ("Annovis" or the "Company"), a clinical-stage drug platform company addressing neurodegenerative diseases, ...

NEW HAVEN, Conn., March 27, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (ARVN), a clinical-stage biotechnology company working to develop a new class of drugs based on targeted protein degradation, today ...

The MarketWatch News Department was not involved in the creation of this content. -Congruence is optimizing several GCase-targeting compounds for GBA-1 Parkinson's disease- MONTREAL, June 3, 2025 /CNW ...

SAN CARLOS, Calif.--(BUSINESS WIRE)--Acurex Biosciences Corporation, a privately-held biopharmaceutical company with a mission to stop neurodegeneration before it starts, has been selected to present ...

BENGALURU: “It is estimated that in the next decade, China will have over half of the new cases of Parkinson’s disease ...

We want to provide support for people in Monterey County who are on the journey of Parkinson's disease, which is quite a journey,” says Terrill Dahl, POP board secretary.